Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The Company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.
Lexington, US
Size (employees)
128 (est)+5%
Quanterix was founded in 2007 and is headquartered in Lexington, US
Report incorrect company information

Key People/Management at Quanterix

David Duffy

David Duffy

CTO & VP, Research
David Wilson

David Wilson

VP, Product Development
James Drummey

James Drummey

Senior Director, Manufacturing Operations

Quanterix Office Locations

Quanterix has offices in Seattle, Austin, Philadelphia, Lexington and in 5 other locations
Lexington, US (HQ)
113 Hartwell Ave
Show all (9)
Report incorrect company information

Quanterix News and Updates

Scientists may have found a way to test football players for CTE before it kills them

The trouble with diagnosing chronic traumatic encephalopathy (CTE), a condition that shows up in the overwhelming majority of American football players and other athletes who…

5 Ways to Improve Your Relationship with the Board

The relationship between the CEO/entrepreneur and the board of directors is unique in business. Here are some suggestions for how to master it.
Report incorrect company information